The Effect of Octreotide on Wound Drainage After Mastectomy

• Status: Completed
• Trial end date: 2021-12-02
• Target enrollment: 0
• Participant gender: Female

Summary

Patients who had mastectomy for breast cancer usually have drainage of some fluid from the site of surgery. This could be prolonged and may lead to other negative consequences after surgery.1 Octreotide could potentially reduce the amount of this drainage.2 In this study, patients were grouped into two: a first group that received octreotide injection and a second group that received a placebo. The study tested whether octreotide injection has any effect on the duration of fluid drainage from the surgery site after mastectomy for breast cancer.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ikechukwu Bartholomew Ulasi
• Treatments: Octreotide

Criteria

Inclusion Criteria:

• All female breast cancer patients requiring modified radical mastectomy

Exclusion Criteria:

• All mastectomies without axillary clearance (simple and toilet mastectomies)

• Breast-conserving surgeries

• Patients undergoing immediate breast reconstruction after mastectomy

• Previous axillary surgery